Product Details for: Rystiggo

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Subcutaneous
280MG/2ML (140MG/ML)
Single-Dose Vial
351(a)
Rystiggo
Rx
002
Injection
Subcutaneous
420MG/3ML (140MG/ML)
Single-Dose Vial
351(a)
Rystiggo
Rx
003
Injection
Subcutaneous
560MG/4ML (140MG/ML)
Single-Dose Vial
351(a)
Rystiggo
Rx
004
Injection
Subcutaneous
840MG/6ML (140MG/ML)
Single-Dose Vial
351(a)
Rystiggo
Rx
Proper Name
rozanolixizumab-noli
BLA Number
761286
Applicant
UCB, Inc.
Original Approval Date
June 26, 2023
Date of First Licensure
RETURN TO SEARCH RESULTS